Genpact Limited (G)

Return on equity (ROE)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands 513,670 663,064 647,839 642,101 631,255 429,658 407,908 363,326 353,404 336,777 343,320 374,354 369,448 371,345 354,394 313,851 308,276 315,492 318,177 329,738
Total stockholders’ equity US$ in thousands 2,389,610 2,394,690 2,337,760 2,298,370 2,248,390 2,009,450 1,932,860 1,925,330 1,826,160 1,731,850 1,750,440 1,847,390 1,897,130 1,952,890 1,838,970 1,749,620 1,834,230 1,777,180 1,660,610 1,573,080
ROE 21.50% 27.69% 27.71% 27.94% 28.08% 21.38% 21.10% 18.87% 19.35% 19.45% 19.61% 20.26% 19.47% 19.02% 19.27% 17.94% 16.81% 17.75% 19.16% 20.96%

December 31, 2024 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $513,670K ÷ $2,389,610K
= 21.50%

Based on the provided data, Genpact Limited's return on equity (ROE) has demonstrated fluctuations over the observed period. The ROE started at 20.96% on March 31, 2020, showing a relatively strong performance. However, there was a gradual decline in ROE over the subsequent quarters, reaching its lowest point of 16.81% on December 31, 2020.

From early 2021, there was a recovery in the ROE, with an upward trend observed until March 31, 2024. Notably, the ROE peaked at 28.08% on December 31, 2023, demonstrating significant improvement and a strong performance during that period.

The ROE then decreased slightly in the subsequent quarters, recording 21.50% on December 31, 2024. Overall, Genpact Limited's ROE has displayed volatility but generally maintained at moderate to high levels, with some quarters showing exceptional performance. This indicates the company's ability to generate profits from shareholders' equity, though ongoing monitoring is necessary to assess the sustainability of this trend.


Peer comparison

Dec 31, 2024

Company name
Symbol
ROE
Genpact Limited
G
21.50%
Exponent Inc
EXPO
28.18%
FTI Consulting Inc
FCN
13.87%